ArticleOncotargetPublished
Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF mutational status
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Oncotarget
- Published
- Topic
- Disease research
- Subject terms
- Cell Line, Tumor; Animals; Humans; Mice; Gastrointestinal Neoplasms; Neovascularization, Pathologic; Phenylurea Compounds; Pyridines; Uracil; Thymine; Pyrrolidines; Proto-Oncogene Proteins B-raf
- PubMed ID
- 38953895
- PubMed Central ID
- PMC11218792
- Open access
- Yes, open
- Added to directory
- Source checked